NewGenIvf Group Limited
NIVF
$0.63
$0.034.11%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.77M | 5.10M | 5.43M | 5.68M | 5.68M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.77M | 5.10M | 5.43M | 5.68M | 5.68M |
| Cost of Revenue | 3.26M | 3.44M | 3.61M | 4.19M | 4.30M |
| Gross Profit | 1.50M | 1.66M | 1.83M | 1.48M | 1.39M |
| SG&A Expenses | 5.62M | 4.30M | 2.99M | 1.32M | 1.34M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.88M | 7.74M | 6.59M | 5.52M | 5.64M |
| Operating Income | -4.11M | -2.64M | -1.16M | 161.50K | 48.20K |
| Income Before Tax | 125.00K | -417.90K | -960.80K | -122.50K | 15.70K |
| Income Tax Expenses | -486.70K | -486.70K | -486.70K | -83.70K | -83.70K |
| Earnings from Continuing Operations | 0.61 | 0.07 | -0.47 | -0.04 | 0.10 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -14.80K | -32.70K | -50.60K | -42.00K | -57.90K |
| Net Income | 596.90K | 36.10K | -524.70K | -80.90K | 41.50K |
| EBIT | -4.11M | -2.64M | -1.16M | 161.50K | 48.20K |
| EBITDA | -4.10M | -2.62M | -1.14M | 206.10K | 88.00K |
| EPS Basic | -3.06 | -23.91 | -44.76 | -26.31 | -24.35 |
| Normalized Basic EPS | -12.65 | -13.49 | -14.33 | 5.35 | 6.19 |
| EPS Diluted | -4.96 | -24.86 | -44.76 | -26.34 | -24.38 |
| Normalized Diluted EPS | -13.86 | -14.09 | -14.33 | 5.35 | 6.19 |
| Average Basic Shares Outstanding | 590.90K | 315.00K | 39.10K | 32.90K | 22.80K |
| Average Diluted Shares Outstanding | 2.03M | 1.05M | 59.30K | 53.10K | 43.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |